Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry-Reference-Cited by-同舟云学术

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry

Published:2023-08 Issue: Volume:202 Page:110766
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Paolisso Pasquale^ORCID,Bergamaschi Luca^ORCID,Cesaro Arturo^ORCID,Gallinoro Emanuele,Gragnano Felice^ORCID,Sardu Celestino^ORCID,Mileva Niya,Foà Alberto,Armillotta Matteo^ORCID,Sansonetti Angelo,Amicone Sara,Impellizzeri Andrea,Belmonte Marta^ORCID,Esposito Giuseppe,Morici Nuccia^ORCID,Andrea Oreglia Jacopo,Casella Gianni,Mauro Ciro,Vassilev Dobrin,Galie Nazzareno,Santulli Gaetano^ORCID,Calabrò Paolo,Barbato Emanuele,Marfella Raffaele^ORCID,Pizzi Carmine

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. Empagliflozin and progression of kidney disease in type 2 diabetes;Wanner;N Engl J Med,2016

2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

3. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019

4. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;Perkovic;N Engl J Med,2019

5. Dapagliflozin in patients with chronic kidney disease;Heerspink;N Engl J Med,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRPA1 protects against contrast-induced renal tubular injury by preserving mitochondrial dynamics via the AMPK/DRP1 pathway;Free Radical Biology and Medicine;2024-09

2. SGLT2 inhibition leads to a restoration of hepatic and circulating metabolites involved in the folate cycle and pyrimidine biosynthesis;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01

3. Impact of SGLT2 Inhibitors on Renal Function in Type 2 Diabetic Patients with Coronary Artery Disease Undergoing Percutaneous Intervention: A Systematic Review and Meta-Analysis;Current Diabetes Reviews;2024-07-03

4. Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?;Clinical Therapeutics;2024-07

5. Spironolactone for Preventing Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease;Angiology;2024-04-28